Gene · 3047
Papers4,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRISPR-Cas Technology as a Revolutionary Genome Editing tool: Mechanisms and Biomedical Applications. | Iran Biomed J | 2023 | 37873636 | PubTator, text mining | PubMed |
| The blood count as a compass to navigate in the ever-changing landscape of the carrier state of hemoglobinopathies: a single-center Italian experience. | Front Pediatr | 2023 | 37868262 | PubTator, text mining | PubMed |
| Relationship between aging and control of metabolic syndrome with telomere shortening: a cross-sectional study. | Sci Rep | 2023 | 37857729 | PubTator, text mining | PubMed |
| Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis. | JAMA Netw Open | 2023 | 37851445 | PubTator, text mining | PubMed |
| Differential transcriptome response following infection of porcine ileal enteroids with species A and C rotaviruses. | Virol J | 2023 | 37848925 | PubTator, text mining | PubMed |
| Fertility-preserving myeloablative conditioning using single-dose CD117 antibody-drug conjugate in a rhesus gene therapy model. | Nat Commun | 2023 | 37828021 | PubTator, text mining | PubMed |
| Molecular understanding of unusual HbE-β+-thalassemia with Hb phenotype similar to HbE heterozygote: simple and rapid differentiation using HbE levels. | Ann Med | 2023 | 37816374 | PubTator, text mining | PubMed |
| Compact engineered human mechanosensitive transactivation modules enable potent and versatile synthetic transcriptional control. | Nat Methods | 2023 | 37813990 | PubTator, text mining | PubMed |
| Hydroxyurea does not reverse functional alterations of the nitric oxide-cGMP pathway associated with priapism phenotype in corpus cavernosum from sickle cell mouse. | PLoS One | 2023 | 37812620 | PubTator, text mining | PubMed |
| Human cellular model systems of β-thalassemia enable in-depth analysis of disease phenotype. | Nat Commun | 2023 | 37803026 | PubTator, text mining | PubMed |
| The clinical value of hsa-miR-190b-5p in peripheral blood of pediatric β-thalassemia and its regulation on BCL11A expression. | PLoS One | 2023 | 37796993 | PubTator, text mining | PubMed |
| Insight into microRNAs' involvement in hematopoiesis: current standing point of findings. | Stem Cell Res Ther | 2023 | 37794439 | PubTator, text mining | PubMed |
| Current approaches and potential challenges in the delivery of gene editing cargos into hematopoietic stem and progenitor cells. | Front Genome Ed | 2023 | 37780116 | PubTator, text mining | PubMed |
| Non-Viral Episomal Vector Mediates Efficient Gene Transfer of the β-Globin Gene into K562 and Human Haematopoietic Progenitor Cells. | Genes (Basel) | 2023 | 37761914 | PubTator, text mining | PubMed |
| Red Blood Cells from Individuals with Lesch-Nyhan Syndrome: Multi-Omics Insights into a Novel S162N Mutation Causing Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency. | Antioxidants (Basel) | 2023 | 37760001 | PubTator, text mining | PubMed |
| The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies. | Biology (Basel) | 2023 | 37759601 | PubTator, text mining | PubMed |
| Phosphoproteomics reveals content and signaling differences between neonatal and adult platelets. | bioRxiv | 2023 | 37745418 | PubTator, text mining | PubMed |
| miR-365-3p mediates BCL11A and SOX6 erythroid-specific coregulation: A new player in HbF activation. | Mol Ther Nucleic Acids | 2023 | 37744176 | PubTator, text mining | PubMed |
| Biological and physico-chemical characterization of human norovirus-like particles under various environmental conditions. | Colloids Surf B Biointerfaces | 2023 | 37741147 | PubTator, text mining | PubMed |
| HEXIM1 is an essential transcription regulator during human erythropoiesis. | Blood | 2023 | 37738561 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3047/papers?page=14